DUSP22 and lung carcinoma: Considering the dephosphorylation function of DUSP22, we performed a phosphokinase array to identify kinases in both HCC827 (gefitinib-sensitive) and H1650 (gefitinib-resistant) lung cancer cells in the presence or absence of DUSP22 shRNA (± gefitinib for HCC827).